Screener
Altimmune ALT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Altimmune’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts and other receivables | 1,665 | 1,219 |
| Income tax and R&D incentive receivables | — | 518 |
| Prepaid expenses and other current assets | 1,429 | 2,957 |
| Total current assets | 334,676 | 278,192 |
| Property and equipment, net | 208 | 312 |
| Other assets | 746 | 1,425 |
| Total assets | $335,630 | $279,929 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
Item 1. Financial Statements
FAQ
- What is Altimmune's total current assets?
- Altimmune (ALT) reported total current assets of $334.68M in Q1 2026.
- How has Altimmune's total current assets changed year-over-year?
- Altimmune's total current assets increased by 115.6% year-over-year, from $155.26M to $334.68M.
- What is the long-term trend for Altimmune's total current assets?
- Over 5 years (2020 to 2025), Altimmune's total current assets has grown at a 3.9% compound annual growth rate (CAGR), from $230.26M to $278.19M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Altimmune's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude